Comparison
Huperzine A vs CDP-Choline
Huperzine A
Potent acetylcholinesterase inhibitor derived from Chinese club moss. Studied for Alzheimer's treatment in China.
CDP-Choline
Cytidine 5'-diphosphocholine. Delivers both choline (for acetylcholine synthesis) and cytidine (for uridine and synaptic membrane synthesis), giving it a dual mechanism that distinguishes it from Alpha-GPC. The most-validated choline source for stroke recovery and age-related cognitive decline.
| Field | Huperzine A | CDP-Choline |
|---|---|---|
| Category | cholinergic | cholinergic |
| Dose range | 0.05–0.2mg | 250–500mg |
| Half-life | 12h | 56h |
| Onset | 60min | 60min |
| Evidence | EVIDENCEA | EVIDENCEA |
| Safety | ●●●○○ | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 380 | 420 |
The comparison in plain English
Auto-generated from dataHuperzine A and CDP-Choline are both in the cholinergic category respectively. Huperzine A Potent acetylcholinesterase inhibitor derived from Chinese club moss. CDP-Choline Cytidine 5'-diphosphocholine.
Bottom line
Huperzine A (evidence A, safety 3/5) matches the evidence base of CDP-Choline (evidence A, safety 5/5). CDP-Choline has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Huperzine A if
Huperzine A is the better fit when your goal aligns with its mechanism (Reversibly inhibits acetylcholinesterase, preventing the breakdown of acetylcholine in synaptic clefts and prolonging cholinergic signalling) and the dose range (0.05–0.2mg) suits your protocol. Half-life is 12h.
Choose CDP-Choline if
CDP-Choline is the better fit when your goal aligns with its mechanism (Hydrolysed into choline and cytidine in the gut) and the dose range (250–500mg) suits your protocol. Half-life is 56h.